Simulations Plus, Inc. (SLP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
8.81-0.01 (-0.16%)
As of 10:57 AM EDT. Market open.
People also watch:
SILCSPNSGVPDWCHSGRP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open8.98
Prev Close8.82
Bid8.77 x 100
Ask8.86 x 100
Day's Range8.77 - 9.18
52wk Range6.74 - 11.89
1y Target EstN/A
Market Cap150.16M
P/E Ratio (ttm)32.61
Beta-1.24
Volume70,160
Avg Vol (3m)27,390
Dividend & Yield0.20 (2.28%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire4 days ago

    Simulations Plus Joins European SimInhale Consortium

    Simulations Plus, Inc. , a leading provider of modeling and simulation software for pharmaceutical discovery and development, today announced that it has been accepted into the SimInhale COST Action, a consortium composed of approximately 100 current university, research institute, and industry members from across Europe.

  • Business Wire18 days ago

    Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016

    Simulations Plus, Inc. , a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fiscal fourth quarter and full fiscal year 2016 ended August 31, 2016.

  • Business Wirelast month

    Simulations Plus Releases PKPlus™ Version 1.0

    Simulations Plus, Inc. , the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released version 1.0 of PKPlus, its next-generation software for analysis of preclinical and clinical trial data.